ライフサイエンスコーパス: Waldenstrom's macroglobulinemia

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 XCR4(WHIM) mutations are highly prevalent in Waldenstrom's macroglobulinemia.

2 at we previously analyzed from patients with Waldenstrom's macroglobulinemia.

3 thy of uncertain significance, and 1 case of Waldenstrom's macroglobulinemia.

4 ponses, and safe in pretreated patients with Waldenstrom's macroglobulinemia.

5 d lymphoplasmacytic lymphoma with or without Waldenstrom's macroglobulinemia (10).

6 Among the patients with Waldenstrom's macroglobulinemia, a somatic variant (T-->

7 in tumor samples from 49 of 54 patients with Waldenstrom's macroglobulinemia and in 3 of 3 patients w

8 t(9;14)(p13;q32), previously associated with Waldenstrom's macroglobulinemia and lymphoplasmacytoid l

9 inemia that can be useful in differentiating Waldenstrom's macroglobulinemia and non-IgM LPL from B-c

10 Two patients with Waldenstrom's macroglobulinemia and one patient with HD

11 utation in benign monoclonal IgM gammopathy, Waldenstrom's macroglobulinemia, and diffuse large B cel

12 CD56(-) MM cell lines, as well as a CD56(-) Waldenstrom's macroglobulinemia cell line.

13 n, as well as NF-kappaB nuclear staining, in Waldenstrom's macroglobulinemia cells expressing MYD88 L

14 A monoclonal IgM from a patient with Waldenstrom's macroglobulinemia hydrolyzed Abeta40 at th

15 Waldenstrom's macroglobulinemia is an incurable, IgM-sec

16 nsus panels of the International Workshop on Waldenstrom's Macroglobulinemia (IWWM).

17 lly with thymoma, a myopathy associated with Waldenstrom's macroglobulinemia, Lambert-Eaton myastheni

18 (n = 4, 22%), multiple myeloma (n = 2, 11%), Waldenstrom's macroglobulinemia (n = 2, 11%), extranodal

19 red normal tissue samples from patients with Waldenstrom's macroglobulinemia or non-IgM LPL and in B

20 commonly recurring mutation in patients with Waldenstrom's macroglobulinemia that can be useful in di

21 e of a 77-year-old white man with history of Waldenstrom's macroglobulinemia transforming to large B-

22 found among RFs from HID or individuals with Waldenstrom's macroglobulinemia who do not have joint di

23 of ibrutinib in 63 symptomatic patients with Waldenstrom's macroglobulinemia who had received at leas

24 In addition, 2 of 3 patients with Waldenstrom's macroglobulinemia who had wild-type MYD88

25 of bone marrow LPL cells in 30 patients with Waldenstrom's macroglobulinemia, with paired normal-tiss

26 ples from patients with multiple myeloma and Waldenstrom's macroglobulinemia without invasive fungal

27 Waldenstrom's macroglobulinemia (WM) is a distinct clini

28 Waldenstrom's macroglobulinemia (WM) is characterized by

29 8 (L265P) is a recurring somatic mutation in Waldenstrom's macroglobulinemia (WM).

30 Rituximab is an important therapeutic for Waldenstrom's macroglobulinemia (WM).

31 malignant B cells derived from patients with Waldenstrom's macroglobulinemia (WM).

32 atment-related peripheral neuropathy (PN) in Waldenstrom's macroglobulinemia (WM).

33 ificance (MGUS), multiple myelomas (MM), and Waldenstrom's macroglobulinemias (WM) using protein macr

34 four small lymphocytic lymphomas (SLL), two Waldenstrom's macroglobulinemias (WM), and one marginal

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。